Phase I trial of TRO 40303 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 31 Aug 2011
At a glance
- Drugs TRO 40303 (Primary)
- Indications Myocardial infarction; Myocardial reperfusion injury
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Trophos
- 31 Aug 2011 Results presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.
- 10 Mar 2011 New trial record
- 24 Feb 2011 Preliminary results presented in a Trophos media release.